Therapeutic efficacy and the treatment of psychoses over the last three decades.
D000328:Adult; D001714:Bipolar Disorder / Q000188:drug therapy / Q000628:therapy; D003295:Convulsive Therapy; D004565:Electroconvulsive Therapy; D005260:Female; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use; D010259:Paranoid Disorders / Q000628:therapy; D010433:Pentylenetetrazole / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011613:Psychotherapy; D011618:Psychotic Disorders / Q000628:therapy*; D012110:Reserpine / Q000627:therapeutic use; D012189:Retrospective Studies; D012559:Schizophrenia / Q000188:drug therapy / Q000628:therapy
D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D012110:Reserpine; D007099:Imipramine; D010433:Pentylenetetrazole